Impaired autophagy in amyloid-beta pathology: A traditional review of recent Alzheimer's research

Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder. The major pathological changes in AD progression are the generation and accumulation of amyloid-beta (A beta) peptides as well as the presence of abnormally hyperphosphorylated tau proteins in the brain. Autophagy is a conserved degradation pathway that eliminates abnormal protein aggregates and damaged organelles. Previous studies have suggested that autophagy plays a key role in the production and clearance of A beta peptides to maintain a steady-state of A beta peptides levels. However, a growing body of evidence suggests that autophagy is significantly impaired in the pathogenesis of AD, especially in A beta metabolism. Therefore, this article reviews the latest studies concerning the mechanisms of autophagy, the metabolism of A beta peptides, and the defective autophagy in the production and clearance of A beta peptides. Here, we also summarize the established and new strategies for targeting autophagy in vivo and through clinical AD trials to identify gaps in our knowledge and to generate further questions.